The Patent Finder

Tanox Biosystems, Inc.

Also on record
Records under this name other than patents Tanox Biosystems, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to Tanox Biosystems, Inc.

PatentTitleStatus Expires Confidence
US 6,657,050Chimeric viral-neutralizing immunoglobulins
Formerly held
Lapsed on the fee record
Ended Dec 2, 2015 · From the USPTO record
Lapsed on the fee recordEnded Dec 2, 2015From the USPTO record
US 6,197,298Modified binding molecules specific for T lymphocytes and their use as in vivo immune modulators in animals
Formerly held
Lapsed on the fee record
Ended Mar 6, 2013 · From the USPTO record
Lapsed on the fee recordEnded Mar 6, 2013From the USPTO record
US 6,129,916Method of Increasing activation on proliferation of T cells using antibody-microbead conjugates
Formerly held
Lapsed on the fee record
Ended Oct 10, 2012 · From the USPTO record
Lapsed on the fee recordEnded Oct 10, 2012From the USPTO record
US 6,117,982Conjugates of microbeads and antibodies specific for T lymphocytes and their use as in vivo immune modulators
Formerly held
Lapsed on the fee record
Ended Sep 12, 2012 · From the USPTO record
Lapsed on the fee recordEnded Sep 12, 2012From the USPTO record
US 6,106,835Modified binding molecules specific for T or B lymphocytes and their use as in vivo immune modulators
Formerly held
Lapsed on the fee record
Ended Aug 22, 2012 · From the USPTO record
Lapsed on the fee recordEnded Aug 22, 2012From the USPTO record
US 6,072,035Reshaped monoclonal antibodies against an immunoglobulin isotype
Lapsed on the fee record
Ended Jun 6, 2012 · From the USPTO record
Lapsed on the fee recordEnded Jun 6, 2012From the USPTO record
US 6,066,718Reshaped monoclonal antibodies against an immunoglobulin isotype
Lapsed on the fee record
Ended May 23, 2012 · From the USPTO record
Lapsed on the fee recordEnded May 23, 2012From the USPTO record
US 6,685,930Methods and substances for recruiting therapeutic agents to solid tumors
Formerly held
Lapsed on the fee record
Ended Feb 3, 2012 · From the USPTO record
Lapsed on the fee recordEnded Feb 3, 2012From the USPTO record
US 6,309,880Antibodies specific for CD4-binding domain of HIV-1
Formerly held
Lapsed on the fee record
Ended Oct 30, 2009 · From the USPTO record
Lapsed on the fee recordEnded Oct 30, 2009From the USPTO record
US 4,829,010Immunoassay device enclosing matrixes of antibody spots for cell determinations
Term ended
Term ended no later than May 9, 2009 · Low confidence
Term endedTerm ended no later than May 9, 2009Low confidence
10 of 55 patents shown.
Pro members see all 55.
Pro members: see all 55 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited